Skip to main content


Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit

Updates regarding government operating status and resumption of normal operations can be found at

Grant Details

Grant Number: 5R01CA106773-03 Interpret this number
Primary Investigator: Inadomi, John
Organization: University Of California, San Francisco
Project Title: Adherence and the Economics of Colon Cancer Screening
Fiscal Year: 2008
Back to top


DESCRIPTION (provided by applicant): Objectives: In environments with limited economic resources, it is paramount that the cost-effectiveness of competing strategies of management be compared. Our previous work illustrates that the cost-effectiveness of screening to decrease mortality from colorectal cancer (CRC) depends heavily on adherence, and specifically on whether adherence between screening strategies is heterogeneous. The objectives of this study are to: 1. Determine whether there exists heterogeneity in adherence between different CRC screening tests, 2. Utilize prospective rates of adherence to calculate the true incremental cost-effectiveness between competing CRC screening strategies, 3. Identify factors associated with non-adherence to screening. Research Design: Prospective cohort study in which subjects' adherence to CRC screening tests scheduled by their primary care provider (PCP) is measured. Strategies to be evaluated include fecal occult blood testing (FOBT), flexible sigmoidoscopy (FS), colonoscopy, and virtual colonoscopy (VC, when approved for CRC screening). A study survey based on constructs of the Health Belief Model will be administered. Population to be Studied: Patients at average risk for development of CRC. Principal Source of Data: The primary outcome is adherence to CRC screening, defined as completion of the screening strategy scheduled for the subject within 12-months of enrollment, verified through computerized medical records and subject contact. Secondary outcomes include assessment of preventive intention, measured by subject scheduling of CRC tests, calculation of the incremental cost-effectiveness between competing strategies of CRC screening, and identification of survey and demographic items associated with non-adherence to CRC screening. Principal Types of Analysis: Specific objective 1 will compare adherence to FOBT, FS, colonoscopy, and VC. Specific objective 2 will calculate the incremental cost-effectiveness ratio between competing CRC screening strategies incorporating the prospectively derived adherence rates. Specific objective 3 will examine the association between potential predictive factors identified from the study survey and non-adherence to CRC screening. Analytic methods will include Chi-square testing of proportions, linear mixed-effects modeling and logistic regression analysis. PCPs will be examined as random- and fixed-effects in separate models to account for potential clustering of outcomes within PCP practices. Cost-effectiveness analysis will use our published decision analytic models. Public Health: This study will compare adherence to competing screening tests in order to identify the most cost-effectiveness strategy to decrease mortality from CRC. Barriers to screening identified through this study will form the basis of future novel programs to increase CRC screening adherence.

Back to top


Adherence to Competing Strategies for Colorectal Cancer Screening Over 3 Years.
Authors: Liang P.S. , Wheat C.L. , Abhat A. , Brenner A.T. , Fagerlin A. , Hayward R.A. , Thomas J.P. , Vijan S. , Inadomi J.M. .
Source: The American Journal Of Gastroenterology, 2016 Jan; 111(1), p. 105-14.
PMID: 26526080
Related Citations

Development of a Practical Model for Targeting Patient Decision Support Interventions to Promote Colorectal Cancer Screening in Vulnerable Populations.
Authors: Brenner A.T. , Gupta S. , Ko L.K. , Janz N. , Inadomi J.M. .
Source: Journal Of Health Care For The Poor And Underserved, 2016; 27(2), p. 465-78.
PMID: 27180689
Related Citations

Race/Ethnicity and Primary Language: Health Beliefs about Colorectal Cancer Screening in a Diverse, Low-Income Population.
Authors: Brenner A.T. , Ko L.K. , Janz N. , Gupta S. , Inadomi J. .
Source: Journal Of Health Care For The Poor And Underserved, 2015 Aug; 26(3), p. 824-38.
PMID: 26320917
Related Citations

Patient trust in physician influences colorectal cancer screening in low-income patients.
Authors: Gupta S. , Brenner A.T. , Ratanawongsa N. , Inadomi J.M. .
Source: American Journal Of Preventive Medicine, 2014 Oct; 47(4), p. 417-23.
PMID: 25084682
Related Citations

Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies.
Authors: Inadomi J.M. , Vijan S. , Janz N.K. , Fagerlin A. , Thomas J.P. , Lin Y.V. , Muñoz R. , Lau C. , Somsouk M. , El-Nachef N. , et al. .
Source: Archives Of Internal Medicine, 2012-04-09 00:00:00.0; 172(7), p. 575-82.
PMID: 22493463
Related Citations

Non-English speakers attend gastroenterology clinic appointments at higher rates than English speakers in a vulnerable patient population.
Authors: Sewell J.L. , Kushel M.B. , Inadomi J.M. , Yee H.F. .
Source: Journal Of Clinical Gastroenterology, 2009 Aug; 43(7), p. 652-60.
PMID: 19169147
Related Citations

A cost-utility analysis of ablative therapy for Barrett's esophagus.
Authors: Inadomi J.M. , Somsouk M. , Madanick R.D. , Thomas J.P. , Shaheen N.J. .
Source: Gastroenterology, 2009 Jun; 136(7), p. 2101-2114.e1-6.
PMID: 19272389
Related Citations

Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans.
Authors: Rubenstein J.H. , Sonnenberg A. , Davis J. , McMahon L. , Inadomi J.M. .
Source: Gastrointestinal Endoscopy, 2008 Nov; 68(5), p. 849-55.
PMID: 18547567
Related Citations

A pilot study of the association of low plasma adiponectin and Barrett's esophagus.
Authors: Rubenstein J.H. , Dahlkemper A. , Kao J.Y. , Zhang M. , Morgenstern H. , McMahon L. , Inadomi J.M. .
Source: The American Journal Of Gastroenterology, 2008 Jun; 103(6), p. 1358-64.
PMID: 18510610
Related Citations

Management of obscure occult gastrointestinal bleeding: a cost-minimization analysis.
Authors: Somsouk M. , Gralnek I.M. , Inadomi J.M. .
Source: Clinical Gastroenterology And Hepatology : The Official Clinical Practice Journal Of The American Gastroenterological Association, 2008 Jun; 6(6), p. 661-70.
PMID: 18550005
Related Citations

Cost utility of screening for Barrett's esophagus with esophageal capsule endoscopy versus conventional upper endoscopy.
Authors: Rubenstein J.H. , Inadomi J.M. , Brill J.V. , Eisen G.M. .
Source: Clinical Gastroenterology And Hepatology : The Official Clinical Practice Journal Of The American Gastroenterological Association, 2007 Mar; 5(3), p. 312-8.
PMID: 17368230
Related Citations

Back to Top